FCN-437c: Clinical Trials

1 trial of FCN-437c, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Unknown 1

Follow FCN-437c: new trials by email Literature Review of FCN-437c trials Research Report on FCN-437c

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
This is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c Versus Placebo in Combination With Letrozole or Anastrozole ± Goserelin in Women With HR+ and HER2- Advanced Breast Cancer.
FCN-437c, Letrozole or anastrozole, Goserelin acetate, Placebo, Letrozole or anastrozole, Goserelin acetate - Advanced Breast Cancer, Female Breast Cancer
Phase 3UnknownAhon Pharmaceutical Co., Ltd.4342022-03-022022-07-06

Sponsors

Ahon Pharmaceutical Co., Ltd. (1)

Countries

China (1)

Top investigators

Binghe Xu (1)

Results publications

PMID 42224659